What the changes say
- Policy changes by the U.S. presidential administration have frozen sustainability incentives, slowing the adoption rate of Bovaer.
- Changes to international tariffs, trade policies, and global tax initiatives like OECD Pillar Two introduce fresh operational risks.
- Goodwill grew to $4,779 million and identifiable intangible assets to $3,408 million, escalating asset valuation risks.
What changed since the prior 10-K
New
- NewStrategic and Operational Risks
produce information for business decision-making activities, we could experience a material adverse impact on our business, including increased costs, data integrity and/or cybersecurity risks and an inability to timely and accurately report our financial results
Future acquisitions could dilute existing shareholders, increase debt, and generate higher amortization expenses that adversely affect financial results.
- NewStrategic and Operational Risks
business partners could be harmed, perhaps materially so. Further, if an IT system failure or outage were to delay or impair our ability to timely report our financial condition and results of operations, our reputation and/or relationships with shareholders could be harmed
IT system implementations or cybersecurity breaches could disrupt operations, compromise sensitive data, and delay financial reporting.
Dropped
- DroppedStrategic and Operational Risks
receive distributions from our subsidiaries, we may be unable to make required principal and interest payments on our indebtedness
- DroppedStrategic and Operational Risks
Two did not have a material impact to income taxes in 2024, to the extent additional changes take place in the countries in which we operate, it is possible these legislative changes may have an adverse impact on our effective tax rates and the amount of income tax we are required to pay
Reworded
- 86% rewrittenLegal and Regulatory Compliance Risks
If the acceptance and/or adoption of our farm animal sustainability initiatives do not continue, our future results may be materially impacted
Added that the 2025 U.S. presidential administration froze government sustainability incentives, tempering adoption of the Bovaer product.
- 80% rewrittenStrategic and Operational Risks
We depend on sophisticated information technology (IT) systems and infrastructure
Broadened IT risks from financial reporting to overall business operations and customer relationships.
Was: We depend on sophisticated information technology (IT) and infrastructure
- 80% rewrittenStrategic and Operational Risks
We may incur additional tax expense or become subject to additional tax exposure
Added specific reference to the OECD Pillar Two initiative and potential retroactive tax law changes.
- 68% rewrittenStrategic and Operational Risks
Changes in interest rates may adversely affect our earnings and/or cash flows
Included EURIBOR in addition to Term SOFR as a variable interest rate exposure.
- 60% rewrittenStrategic and Operational Risks
We may be required to write down goodwill or other identifiable intangible assets
Updated 2025 carrying values to $4,779 million for goodwill and $3,408 million for identifiable intangibles.
Was: We may be required to write down goodwill or identifiable intangible assets
- 55% rewrittenLegal and Regulatory Compliance Risks
Tariffs, trade protection measures or other modifications of foreign trade policy may harm us or our customers
Added that tariffs in key markets changed during 2025 and 2026, and expanded supply chain exposure to Europe.
- 54% rewrittenLegal and Regulatory Compliance Risks
Our insurance policies may be insufficient to protect against all potential hazards or litigation claims
Refined language regarding the evaluation of insurance coverage limits and prohibitively expensive policies.
- 54% rewrittenLegal and Regulatory Compliance Risks
We may incur substantial costs and receive adverse outcomes in litigation, regulatory investigations and other legal matters
Added potential penalties alongside damages for adverse litigation outcomes.
- 53% rewrittenStrategic and Operational Risks
We may not be able to successfully complete favorable transactions or successfully integrate acquired businesses when we pursue acquisitions, divestitures, joint ventures or other significant transactions
- 52% rewrittenStrategic and Operational Risks
Our results of operations may be adversely affected by foreign currency exchange rate fluctuations
- 51% rewrittenRisks Related to the Animal Health Industry
Our R&D, acquisition and licensing efforts may fail to generate commercially successful new products or to expand the use of our existing products
- 50% rewrittenLegal and Regulatory Compliance Risks
Unanticipated safety, quality or efficacy concerns or identified concerns associated with our products may harm our reputation and have an adverse impact on our performance
- 50% rewrittenStrategic and Operational Risks
Changes in our credit ratings could increase our interest expense and restrict our access to, and negatively impact the terms of, current or future financings or trade credit
- 48% rewrittenStrategic and Operational Risks
We do not anticipate paying dividends on our common stock in the foreseeable future
- 48% rewrittenStrategic and Operational Risks
We may not be able to successfully implement future restructuring activities or other significant organizational changes
- 47% rewrittenRisks Related to the Animal Health Industry
Generic products may be viewed as more cost-effective than our products
- 45% rewrittenStrategic and Operational Risks
We use machine learning and artificial intelligence (AI) in our business, and challenges with properly managing its use could result in operational, competitive or reputational harm and legal liability
- 44% rewrittenLegal and Regulatory Compliance Risks
If our intellectual property rights are challenged or circumvented, competitors may be able to take advantage of our R&D efforts or harm the value of our brands
- 42% rewrittenRisks Related to the Animal Health Industry
An outbreak of infectious disease carried by farm animals could negatively affect the demand for, and sale and production of, our farm animal products
- 41% rewrittenRisks Related to the Animal Health Industry
Regulatory restrictions and bans on the use of antibiotics and productivity products in farm animals, as well as changing market demand, may continue to negatively affect demand for certain of our farm animal products
- 39% rewrittenLegal and Regulatory Compliance Risks
Our business is subject to substantial regulation
- 39% rewrittenStrategic and Operational Risks
Manufacturing challenges and capacity imbalances, including at our contract manufacturers, have caused, and may in the future cause, product launch delays, inventory shortages, recalls and/or unanticipated costs
Was: Manufacturing problems and capacity imbalances, including at our contract manufacturers, have caused, and may in the future cause, product launch delays, inventory shortages, recalls and/or unanticipated costs
- 36% rewrittenLegal and Regulatory Compliance Risks
We may be unable to achieve our aspirations set forth in our ESG report(s), particularly with respect to the reduction of greenhouse gas (GHG) emissions or otherwise meet the expectations of our stakeholders with respect to ESG matters
Was: We may be unable to achieve our goals and aspirations set forth in our ESG report(s), particularly with respect to the reduction of greenhouse gas (GHG) emissions, or otherwise meet the expectations of our stakeholders with respect to ESG matters
- 35% rewrittenLegal and Regulatory Compliance Risks
The actual or purported intellectual property rights of third parties may negatively affect our business
- 34% rewrittenLegal and Regulatory Compliance Risks
Increased regulation or decreased governmental financial support relating to the raising, processing or consumption of farm animals could reduce demand for our farm animal products
- 28% rewrittenStrategic and Operational Risks
We have substantial indebtedness
- 28% rewrittenStrategic and Operational Risks
Our results of operations are dependent upon the success of our top products
- 24% rewrittenRisks Related to the Animal Health Industry
For our pet health products, increased use of alternative distribution channels, or changes within existing distribution channels, could negatively impact our market share, margins and distribution of our products
- 24% rewrittenStrategic and Operational Risks
Our debt agreements contain restrictions that will limit our flexibility in operating our business
- 23% rewrittenLegal and Regulatory Compliance Risks
Breaches of our IT systems or improper disclosure of confidential company or personal data, or a failure to comply with privacy laws, regulations and our contractual obligations concerning data privacy or the security of certain information, could have a material adverse effect on our reputation and operations
- 23% rewrittenStrategic and Operational Risks
We rely on third parties to provide us with products and materials and are subject to increased material costs and potential disruptions in supply
- 22% rewrittenStrategic and Operational Risks
Our business may be negatively affected by weather conditions, seasonality and the availability of natural resources
Was: Our business may be negatively affected by weather conditions and the availability of natural resources
- 21% rewrittenStrategic and Operational Risks
Increased or decreased inventory levels in our distribution channels can lead to fluctuations in our revenues and levels of inventory on-hand
All 48 risk factors
Headings as the filing states them, in filing order.
Risks Related to the Animal Health Industry
- 01The animal health industry is highly competitive
- 02Our R&D, acquisition and licensing efforts may fail to generate commercially successful new products or to expand the use of our existing products51% rewritten
- 03Disruptive innovation and advances in veterinary medical practices, animal health technologies and alternatives to animal-derived protein could negatively affect the markets for our products
- 04Generic products may be viewed as more cost-effective than our products47% rewritten
- 05Regulatory restrictions and bans on the use of antibiotics and productivity products in farm animals, as well as changing market demand, may continue to negatively affect demand for certain of our farm animal products41% rewritten
- 06An outbreak of infectious disease carried by farm animals could negatively affect the demand for, and sale and production of, our farm animal products42% rewritten
- 07Our R&D relies on evaluations of animals and may become subject to bans, additional restrictive regulations or increased attention from activism movements
- 08Consolidation of our customers and distributors could negatively affect the pricing of our products
- 09For our pet health products, increased use of alternative distribution channels, or changes within existing distribution channels, could negatively impact our market share, margins and distribution of our products24% rewritten
Strategic and Operational Risks
- 10Our results of operations are dependent upon the success of our top products28% rewritten
- 11We may not be able to successfully complete favorable transactions or successfully integrate acquired businesses when we pursue acquisitions, divestitures, joint ventures or other significant transactions53% rewritten
- 12produce information for business decision-making activities, we could experience a material adverse impact on our business, including increased costs, data integrity and/or cybersecurity risks and an inability to timely and accurately report our financial resultsNew
- 13We may not be able to successfully implement future restructuring activities or other significant organizational changes48% rewritten
- 14Manufacturing challenges and capacity imbalances, including at our contract manufacturers, have caused, and may in the future cause, product launch delays, inventory shortages, recalls and/or unanticipated costs39% rewritten
- 15Increased or decreased inventory levels in our distribution channels can lead to fluctuations in our revenues and levels of inventory on-hand21% rewritten
- 16We use machine learning and artificial intelligence (AI) in our business, and challenges with properly managing its use could result in operational, competitive or reputational harm and legal liability45% rewritten
- 17We depend on sophisticated information technology (IT) systems and infrastructure80% rewritten
- 18business partners could be harmed, perhaps materially so. Further, if an IT system failure or outage were to delay or impair our ability to timely report our financial condition and results of operations, our reputation and/or relationships with shareholders could be harmedNew
- 19Our business may be negatively affected by weather conditions, seasonality and the availability of natural resources22% rewritten
- 20We could experience demand, supply and operational challenges associated with the effects of a human disease outbreak, epidemic, pandemic or other widespread public health concern
- 21A loss of key personnel or highly skilled employees could disrupt our operations
- 22Our business could be materially adversely affected by labor disputes, strikes or work stoppages
- 23We have substantial indebtedness28% rewritten
- 24Our debt agreements contain restrictions that will limit our flexibility in operating our business24% rewritten
- 25Changes in our credit ratings could increase our interest expense and restrict our access to, and negatively impact the terms of, current or future financings or trade credit50% rewritten
- 26Changes in interest rates may adversely affect our earnings and/or cash flows68% rewritten
- 27We may be required to write down goodwill or other identifiable intangible assets60% rewritten
- 28We rely on third parties to provide us with products and materials and are subject to increased material costs and potential disruptions in supply23% rewritten
- 29Our operations are subject to the economic, political, legal and business environments of the countries in which we do business
- 30Our results of operations may be adversely affected by foreign currency exchange rate fluctuations52% rewritten
- 31We have underfunded pension plan liabilities. We will require current and future operating cash flows to fund these shortfalls, reducing the cash available for other uses
- 32We do not anticipate paying dividends on our common stock in the foreseeable future48% rewritten
- 33We could be negatively impacted by being a target of shareholder activism, causing us to incur significant expense and hinder or disrupt the execution of our business strategy
- 34We may incur additional tax expense or become subject to additional tax exposure80% rewritten
Legal and Regulatory Compliance Risks
- 35Our business is subject to substantial regulation39% rewritten
- 36If the acceptance and/or adoption of our farm animal sustainability initiatives do not continue, our future results may be materially impacted86% rewritten
- 37Increased regulation or decreased governmental financial support relating to the raising, processing or consumption of farm animals could reduce demand for our farm animal products34% rewritten
- 38Tariffs, trade protection measures or other modifications of foreign trade policy may harm us or our customers55% rewritten
- 39We may incur substantial costs and receive adverse outcomes in litigation, regulatory investigations and other legal matters54% rewritten
- 40The actual or purported intellectual property rights of third parties may negatively affect our business35% rewritten
- 41If our intellectual property rights are challenged or circumvented, competitors may be able to take advantage of our R&D efforts or harm the value of our brands44% rewritten
- 42The illegal distribution and sale by third parties of counterfeit or illegally compounded versions of our products or of stolen, diverted or relabeled products could have a negative impact on our reputation and business
- 43The misuse or off-label use of our products may harm our reputation or result in financial or other damages
- 44Unanticipated safety, quality or efficacy concerns or identified concerns associated with our products may harm our reputation and have an adverse impact on our performance50% rewritten
- 45Our insurance policies may be insufficient to protect against all potential hazards or litigation claims54% rewritten
- 46Breaches of our IT systems or improper disclosure of confidential company or personal data, or a failure to comply with privacy laws, regulations and our contractual obligations concerning data privacy or the security of certain information, could have a material adverse effect on our reputation and operations23% rewritten
- 47We are subject to complex EHS laws and regulations
- 48We may be unable to achieve our aspirations set forth in our ESG report(s), particularly with respect to the reduction of greenhouse gas (GHG) emissions or otherwise meet the expectations of our stakeholders with respect to ESG matters36% rewritten
Other Elanco Animal Health 10-Ks
- FY2024 10-K risk factors48 risks
Elanco faces intense competition, high indebtedness of $4.3 billion, and substantial regulatory oversight across global markets. R&D failures, manufacturing disruptions, and shifting consumer trends toward alternatives could significantly impact product demand.
Filed Feb 25, 2025
About this page
The headings are the filing's own. The one-line readings and the overview are automated and can be wrong: read Item 1A of the 10-K for the exact wording.